查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1197834

器官护理系统 (OCS) 市场——增长、趋势和预测 (2023-2028)

Organ Care Systems (OCS) Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

研究中的器官护理系统 (OCS) 市场预计在预测期内以 9.1% 的复合年增长率增长。

COVID-19 的突然爆发对市场产生了重大影响。 这主要是由于为遏制大流行感染而取消的择期手术导致器官捐献和移植手术减少。 2021 年 12 月发表在 Springer 上的一篇论文指出，器官捐赠减少了 21%，移植减少了 59%。 同一消息来源还指出，由于 COVID-19 大流行，59% 的活体肾臟移植计划已暂停对新捐赠者的评估。 大流行期间器官捐赠和移植的这种下降对市场增长产生了重大影响。 然而，大流行后严格监管的放鬆导致器官捐赠和移植手术的增加，有助于预测期内的市场增长。

市场增长的重要推动力包括导致器官衰竭的各种慢性病发病率不断上升，以及器官移植手术的数量不断增加。 技术发展的进步也有望促进市场增长。

同样，根据英国心臟基金会2022年8月公布的数据，2021年英国将有超过760万人战胜心臟或循环系统疾病。 2022年3月发布的世界肾臟日数据提到，全球约十分之一的人患有慢性肾脏病。 预计导致器官移植的各种疾病的流行将有助于市场的增长。 此外，大量器官移植也被认为是市场增长的推动力。 例如，Print 在 2022 年 5 月发布的数据指出，印度每年进行近 17,000 至 18,000 例实体器官移植。

此外，预计各主要市场参与者增加产品批准和发布也将有助于市场增长。 2021 年 12 月，OrganOx 获得了美国 FDA 对 metra 系统的上市前批准。 metra 是一种全自动 NMP 设备，用于储存和运输供体肝臟以供移植。

因此，预计器官移植手术需求的增加以及产品的批准和开发将有助于预测期内的市场增长。

器官护理系统 (OCS) 市场趋势

心臟部分有望占据较大的市场份额

研究领域的增长归因于心血管疾病发病率的上升和世界人口中心臟移植的增加。

例如，美国心臟杂誌 2021 年 5 月发布的数据指出，美国和加拿大近 1.5% 至 1.9% 的人口患有心力衰竭。 在欧洲，1% 到 2% 的人口患有这种疾病。 此外，该文件称，中国有1210万患者患有心力衰竭，其中25岁以上的患者约有300万人。 心力衰竭患者的增加导致对心臟移植的需求增加。 因此，它有望促进对心臟治疗系统的需求并推动该领域的发展。 此外，根据 Elsevier 2022 年 8 月公布的数据，到 2021 年 4 月，印度新德里 AIIMS 已完成近 1,113 例心臟移植和 101 例心肺移植。 预计如此大量的心臟移植将促进这一细分市场的增长。

此外，各种心臟移植中心的建立预计将推动对器官护理系统 (OCS) 的需求并促进市场增长。 例如，2022年3月，亚洲医学科学研究所（AIMS）与美高梅医疗集团合作，在北印度启动了心肺移植中心，提供简单快捷的器官移植服务。

心臟产品批准的增加也有望促进研究领域的增长。 例如，2022 年 4 月，Transmedics 的器官护理系统 (OCS) 获得了美国 FDA 的批准，这是一种使用脑死亡捐献者器官的心臟系统。

因此，预计在预测期内，大量心臟移植、心血管疾病上升、产品发布增加等将有助于研究领域的增长。

预计北美将占据重要的市场份额

由于器官移植需求的增加和器官捐赠的增加，预计北美将占据重要的市场份额。 此外，器官护理系统（OCS）先进技术的快速引入和主要市场参与者的存在也是北美市场的驱动因素。

例如，Organdonor.gov 于 2022 年 3 月发布的数据指出，大约有 105,800 名患者在国家移植等待名单上。 它还指出，2021 年将进行 40,000 多例移植手术。 同样，CIHI 于 2022 年 6 月发布的数据指出，2021 年加拿大进行了 2,782 例器官移植。 如此大量的器官移植手术和不断增长的器官移植需求预计将有助于该地区的市场增长。 器官衰竭的流行也是一个促成因素。 美国肾臟基金会 2022 年 2 月发布的数据指出，大约 81 万美国人已经克服了肾衰竭，超过 24 万美国人正在接受肾移植。。

同样，北美中心的大量器官移植中心也有望促进市场的增长。 例如，2022 年 1 月发表在 AASLD 上的一篇文章提到，CENTARA 在墨西哥批准了 84 个肝移植中心。 批准的移植中心的这种增加也有望推动对器官护理系统 (OCS) 的需求。

此外，增加产品开发和批准也有望促进该地区的市场增长。 例如，2021年10月，Paragonix Technologies在美国商业化推出了LIVERgaurd Donor Liver Preservation System。 LIVERgaurd 系统为低温肝臟保存提供了一个高度受控的、最先进的环境，并结合实时数字监控，以在整个移植过程中保护供体的肝臟。

因此，大量器官移植和不断增长的移植手术需求，以及主要製造商的存在和频繁的产品发布，将有助于预测期内该地区的市场增长。看来。

器官护理系统 (OCS) 市场竞争对手分析

器官护理系统 (OCS) 市场较为分散，由主要市场参与者组成。 竞争格局包括对几家具有市场份额的知名国际和本地公司的分析。 主要市场参与者是 TransMedics 、 Xvivo Perfusion AB 、 Paragonix Technologies Inc .、 OrganOx Limited 、 Bridge to Life Ltd 等。

其他福利。

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第一章介绍

  • 调查先决条件和市场定义
  • 调查范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

  • 市场概览
  • 市场驱动因素
    • 增加器官衰竭的发生率和增加器官移植
    • 技术开发进展
  • 市场製约因素
    • 缺乏对器官衰竭和器官移植费用高昂的认识
  • 行业吸引力 - 五力分析分析
    • 新进入者的威胁
    • 买家的议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（基于价值的市场规模：百万美元）

  • 按产品分类
    • 手推车
    • 便携式
  • 按器官类型
    • 肾臟
    • 心
    • 由其他机关
  • 最终用户
    • 医院
    • 门诊手术中心
    • 其他最终用户
  • 按地区细分
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 世界其他地区

第六章竞争格局

  • 公司简介
    • TransMedics
    • Xvivo Perfusion AB
    • Bridge to Life Ltd
    • Paragonix Technologies Inc.
    • OrganOx Limited
    • Preservation Solution Inc.
    • Organ assist BV
    • Water Medical System
    • Organ Recovery Systems Inc.

第7章 市场机会今后动向

简介目录
Product Code: 93138

The organ care system market studied is anticipated to grow with a CAGR of 9.1% during the forecast period.

The sudden outbreak of COVID-19 had a significant impact on the market. This was mainly due to the reduction of organ donation and transplantation procedures due to the cancellation of elective procedures to curb the pandemic infection. The article published in Springer in December 2021 mentioned a 21% reduction in organ donation and a 59% reduction in transplants. The source also noted that 59% of living donor kidney transplant programs suspended the evaluation of new donors due to the COVID-19 pandemic. Such reduction in organ donations and transplantation during the pandemic significantly impacted the market growth. However, the relaxation of strict regulations during the post-pandemic increased organ donations and transplant surgeries, thereby contributing to the market's growth over the forecast period.

Some significant market growth factors are the increased incidence of various chronic disorders resulting in organ failures, along with a high volume of organ transplantation surgeries. The rising technological developments are also expected to contribute to the market's growth.

Similarly, according to the data published by the British Heart Foundation in August 2022, in the United Kingdom, over 7.6 million people survived heart or circulatory disease in 2021. The World Kidney day data published in March 2022 mentioned that about 1 in 10 people worldwide have chronic kidney disease. The prevalence of various conditions resulting in organ transplantation is expected to contribute to the market's growth. Additionally, the high organ transplantation volume is expected to drive market growth. For instance, the data published by the print in May 2022 mentioned that nearly 17,000 to 18,000 solid organ transplants are performed in India each year.

Furthermore, the increasing product approvals and launches by various key market players are also expected to contribute to the market's growth. In December 2021, OrganOx received the United States FDA's premarket approval for its metra system. The metra is a fully automated NMP device for preserving and transporting donor livers destined for transplantation.

Thus, the increasing demand for organ transplantation surgeries and product approvals and developments are expected to contribute to the market's growth over the forecast period.

Organ Care Systems (OCS) Market Trends

Heart Segment Expected to Hold a Significant Market Share

The growth of the studied segment is attributed to the growing incidence of cardiovascular diseases and the increasing incidence of heart transplants among the global population.

For instance, the data published by American Heart Journal in May 2021 mentioned that almost 1.5% to 1.9% of the population suffers from heart failure in the United States and Canada. In Europe, 1% to 2% of the population suffers from the disease. The same source also stated that 12.1 million patients were suffering from heart failure in China, while in people over 25 years old, the incidence of the disease was around 3 million. Such increasing cases of heart failure are leading to the growing demand for heart transplants. This is expected to contribute to the demand for heart care systems, thereby driving the segment's growth. Furthermore, according to the data published by the Elsevier article in August 2022, nearly 1,113 heart transplants and 101 heart-lung transplants were performed at AIIMS, New Delhi, India, till April 2021. Such a high volume of heart transplants is expected to drive the segment's growth.

Also, establishing various heart transplant centers is expected to drive the demand for organ care systems, fueling the market's growth. For instance, in March 2022, the Asian Institute of Medical Sciences (AIMS) launched the Heart and lung transplant center in North India in collaboration with MGM healthcare to provide easy and fast organ transplant services.

The increasing product approvals for the heart are also expected to contribute to the growth of the studied segment. For instance, in April 2022, TransMedics, Inc. received approval from the United States FDA for its Organ Care System (OCS) heart systems for use with organs from donors after brain death.

Thus, the high volume of heart transplants, rising cardiovascular diseases, and increasing product launches are expected to contribute to the growth of the studied segment over the forecast period.

North America Expected to Hold a Significant Market Share

North America is expected to hold a significant market share owing to the rising demand for organ transplantations and increasing organ donation. Additionally, the quick adoption of advanced technologies in the organ's care systems and the presence of key market players are driving factors for the North American market.

For instance, the data published by Organdonor.gov in March 2022 mentioned that nearly 105,800 patients were on the national transplant waiting list. The report also noted that more than 40,000 transplants were performed in 2021. Similarly, the CIHI data published in June 2022 mentioned that 2,782 organ transplants were performed in Canada in 2021. Such a high volume of organ transplant surgeries and increasing demand for organ transplantations are expected to contribute to the region's market growth. The prevalence of organ failure is another contributing factor. The data published by American Kidney Fund in February 2022 mentioned that nearly 810,000 Americans survive kidney failure, and over 240,00 Americans live with kidney transplants.

Likewise, the high number of organ transplant centers in North American centers is also expected to contribute to the growth of the market. For instance, the article published in AASLD in January 2022 mentioned that CENTARA had approved 84 centers in Mexico for liver transplants. Such growth in approved transplant centers is also expected to drive the demand for organ care systems.

Furthermore, the increasing product developments and approvals are also expected to contribute to the market growth in this region. For instance, in October 2021, Paragonix Technologies commercially launched the LIVERgaurd Donor Liver Preservation System in the United States. The LIVERgaurd System provides a highly controlled, state-of-the-art environment for hypothermic liver preservation, coupled with real-time digital monitoring to safeguard a donor's liver throughout the transplant process.

Thus, the high volume of organ transplantations and increasing demand for transplant surgeries, along with the presence of key players and frequent product launches, are expected to contribute to the market growth in this region over the forecast period.

Organ Care Systems (OCS) Market Competitor Analysis

The organ care system market is moderately fragmented and consists of major market players. The competitive landscape includes an analysis of a few international as well as local companies which hold market shares and are well-known. The major market players are TransMedics, Xvivo Perfusion AB, Paragonix Technologies Inc., OrganOx Limited, Bridge to Life Ltd, and others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions & Market Definition
  • 1.2 Scope Of The Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Incidence of Organ Failures and Rising Organ Transplantations
    • 4.2.2 Increasing Technological Developments
  • 4.3 Market Restraints
    • 4.3.1 Lack of Awareness Regarding Organ Failure and High Cost for Organ Transplantation
  • 4.4 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product
    • 5.1.1 Trolley
    • 5.1.2 Portable
  • 5.2 By Organ Type
    • 5.2.1 Kidney
    • 5.2.2 Heart
    • 5.2.3 Other Organ Types
  • 5.3 By End-user
    • 5.3.1 Hospitals
    • 5.3.2 Ambulatory Surgical Centers
    • 5.3.3 Other End-users
  • 5.4 By Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of the Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of the Asia-Pacific
    • 5.4.4 Rest of the World

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 TransMedics
    • 6.1.2 Xvivo Perfusion AB
    • 6.1.3 Bridge to Life Ltd
    • 6.1.4 Paragonix Technologies Inc.
    • 6.1.5 OrganOx Limited
    • 6.1.6 Preservation Solution Inc.
    • 6.1.7 Organ assist BV
    • 6.1.8 Water Medical System
    • 6.1.9 Organ Recovery Systems Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS